Getting treatment within one week of a serious head injury can reduce the risk of developing Alzheimer's disease by up to 41% ...

A key gene known for its role in Alzheimer's disease has been found to play a second, damaging role in a different brain ...

Three years after Chris Hemsworth shared he had a gene that elevates his likelihood of developing Alzheimer’s, he detailed ...

Novo Nordisk had hoped to repurpose semaglutide - the active ingredient in its Wegovy and Ozempic jabs - as a groundbreaking ...

Novo Nordisk's highly anticipated but ultimately unsuccessful Alzheimer's trials were a long shot for the maker of ...

Lecanemab, sold under the name Leqembi, is a monoclonal antibody therapy for Alzheimer's disease that clears toxic amyloid ...

A new study suggests you may want to pay better attention to your HDL cholesterol — but not for the reason you might think.

Scientists have found that a mutation tied to Alzheimer’s disrupts the production and quality of exosomes—tiny cell-made ...

Novo Nordisk today announced the top-line results from the 2-year primary analysis of evoke and evoke+ phase 3 trials in ...

Johnson & Johnson ends its Phase 2b posdinemab trial after missing key Alzheimer's goals, raising concerns for ...

Lecanemab, sold under the name Leqembi, is a monoclonal antibody therapy for Alzheimer's disease that clears toxic amyloid ...

LEQEMBI IQLIK, if approved for initiation dosing, would be the first and only anti-amyloid treatment to offer at-home ...